- Report
- October 2024
- 189 Pages
Global
From €3181EUR$3,545USD£2,738GBP
€3534EUR$3,939USD£3,042GBP
- Report
- January 2025
- 100 Pages
Global
From €5339EUR$5,950USD£4,595GBP
- Report
- April 2025
- 89 Pages
Global
From €5249EUR$5,850USD£4,518GBP
- Report
- September 2024
- 187 Pages
Global
From €4038EUR$4,500USD£3,475GBP
- Report
- July 2024
- 155 Pages
Global
From €3813EUR$4,250USD£3,282GBP
- Report
- November 2023
- 234 Pages
Global
From €4442EUR$4,950USD£3,823GBP
- Report
- December 2023
- 167 Pages
Global
From €2221EUR$2,475USD£1,911GBP
€4442EUR$4,950USD£3,823GBP
- Report
- August 2022
- 111 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- January 2025
- 132 Pages
Global
From €852EUR$950USD£734GBP
The FluoroSpot Assay is a type of in vitro diagnostic (IVD) test used to measure the presence of cytokines and other proteins in a sample. It is a quantitative, multiplexed immunoassay that uses fluorescently labeled antibodies to detect and quantify multiple analytes in a single sample. The assay is used to measure the levels of cytokines and other proteins in a variety of clinical samples, including blood, serum, and tissue. It is also used to measure the levels of cytokines and other proteins in cell culture supernatants.
The FluoroSpot Assay market is a growing segment of the IVD market, with a wide range of applications in research and clinical settings. It is used to measure the levels of cytokines and other proteins in a variety of clinical samples, including blood, serum, and tissue. It is also used to measure the levels of cytokines and other proteins in cell culture supernatants.
Some companies in the FluoroSpot Assay market include Bio-Rad Laboratories, Merck KGaA, PerkinElmer, Inc., and Thermo Fisher Scientific. Show Less Read more
